What do we mean when we suggest that outcome measures are the key to optimizing upper-limb prosthetic rehabilitation? The answers to this question are important to a wide range of stakeholders, including current and future patients, clinicians and researchers, prosthetic manufacturers, private insurers, workers’ compensation providers, the U. S. Department of Defense, and government-funded insurance programs.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased